Core Viewpoint - Growth investors are increasingly focusing on stocks with above-average financial growth, and Blachem (BCPC) is highlighted as a strong candidate due to its favorable growth metrics and Zacks Rank [1][2]. Earnings Growth - Blachem's historical EPS growth rate is 0.8%, but projected EPS growth for this year is 16%, surpassing the industry average of 14.9% [3]. Cash Flow Growth - The year-over-year cash flow growth for Blachem is currently at 4%, significantly higher than the industry average of -2.6%. The company's annualized cash flow growth rate over the past 3-5 years is 2.8%, compared to the industry average of 1.1% [4]. Earnings Estimate Revisions - The current-year earnings estimates for Blachem have been revised upward, with the Zacks Consensus Estimate increasing by 0.8% over the past month [5]. Overall Positioning - Blachem has achieved a Zacks Rank 1 (Strong Buy) and a Growth Score of B, positioning it well for potential outperformance in the market [6][7].

MONTVALE, N.J., June 26, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ:BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at the CJS Securities 24th Annual New Ideas Summer Conference on July 10, 2024. Ted Harris, Chairman of the Board, President and Chief Executive Officer, Martin Bengtsson, Chief Financial Officer and Allison Baurichter, Senior Director Investor Relations will present at the conference. About Balchem Corporation Balchem C ...

Company Overview - Balchem Corporation is a global specialty ingredient manufacturer focused on health and nutrition markets [2] - The company operates through three business segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products [2] Business Segments - The Human Nutrition & Health segment provides customized food and beverage ingredient systems and key nutrients for food, supplement, and pharmaceutical applications [2] - The Animal Nutrition & Health segment supplies products to various animal health markets [2] - Specialty Products segment offers specialty-packaged chemicals for healthcare and other industries, as well as chelated minerals for the micronutrient agricultural market [2] Upcoming Events - Balchem Corporation will present at the CJS Securities 24th Annual New Ideas Summer Conference on July 10, 2024 [1] - Key executives including Ted Harris (Chairman, President, and CEO), Martin Bengtsson (CFO), and Allison Baurichter (Senior Director Investor Relations) will represent the company at the conference [1]

MONTVALE, N.J., May 29, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ:BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at the Wells Fargo Industrials Conference on June 12, 2024. Ted Harris, Chairman of the Board, President and Chief Executive Officer, Martin Bengtsson, Chief Financial Officer, and Allison Baurichter, Senior Director Investor Relations will present at the conference. About Balchem Corporation Balchem Corporation develops, ...

MONTVALE, N.J., May 29, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at the Wells Fargo Industrials Conference on June 12, 2024. Ted Harris, Chairman of the Board, President and Chief Executive Officer, Martin Bengtsson, Chief Financial Officer, and Allison Baurichter, Senior Director Investor Relations will present at the conference. About Balchem Corporation Balchem Corporation develops ...

MONTVALE, N.J., May 21, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ:BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will attend the Deutsche Bank Global Consumer Conference on June 4, 2024. Ted Harris, Chairman of the Board, President and Chief Executive Officer, and Martin Bengtsson, Chief Financial Officer will attend the conference. About Balchem Corporation Balchem Corporation develops, manufactures and markets specialty ingredients that improv ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____ to ____ Commission file number: 1-13648 _______________________________________________________________________________________________________________ B ...

Balchem Corporation (NASDAQ:BCPC) Q1 2024 Earnings Conference Call May 3, 2024 8:30 AM ET Company Participants Martin Bengtsson – Chief Financial Officer Ted Harris – Chairman, President and Chief Executive Officer Conference Call Participants Bob Labick – CJS Securities Ram Selvaraju – H.C. Wainwright Kyle May – Sidoti and Company Operator Greetings, and welcome to the Balchem Corporation First Quarter 2024 Earnings Call. At this time all participants are in a listen-only mode. [Operator Instructions] As a ...

Investor Presentation Q1 2024 1 Safe Harbor Statement • During the course of this presentation, management may make forward-looking statements regarding financial performance and future events. • We will attempt to identify these statements by use of words such as expect, believe, anticipate, intend, and other words that denote future events. You should understand that, even though our forward-looking statements are based on assumptions we believe are reasonable when made, they are still subject to uncertai ...

Exhibit 99.1 5 Paragon Drive Montvale, NJ 07645 p.845.326.5600 f. 845.326.5702 Human Nutrition & Health | Animal Nutrition & Health | Specialty Products Balchem Corporation Reports First Quarter 2024 Financial Results First Quarter 2024 Financial Highlights: Recent Highlights: Montvale, NJ, May 3, 2024 - Balchem Corporation (NASDAQ: BCPC) reported today financial results for its 2024 fiscal first quarter ended March 31, 2024. The Company reported quarterly net sales of $239.7 million, quarterly net earnings ...